Literature DB >> 7738914

Synthesis and granular localization of tumor necrosis factor-alpha in activated NK cells in the pregnant mouse uterus.

E L Parr1, H L Chen, M B Parr, J S Hunt.   

Abstract

The synthesis and cellular localization of tumor necrosis factor-alpha (TNF-alpha) were studied in mouse GMG cells, which are activated NK cells in uterine decidual tissue during pregnancy. Synthesis of the protein was demonstrated in GMG cells on days 10 and 14 of pregnancy by in situ hybridization of TNF-alpha message. Immunostaining demonstrated that TNF-alpha protein was localized in the cytoplasmic granules of GMG cells at these times. The results suggest that the cytolytic activity of uterine NK cells may be due in part to TNF-alpha, and that this cytokine may be delivered to target cells intracellularly via transmembrane pores formed by perforin, which is also localized in uterine NK cell granules.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7738914     DOI: 10.1016/0165-0378(94)00905-m

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  4 in total

1.  Engraftment of bone marrow from severe combined immunodeficient (SCID) mice reverses the reproductive deficits in natural killer cell-deficient tg epsilon 26 mice.

Authors:  M J Guimond; B Wang; B A Croy
Journal:  J Exp Med       Date:  1998-01-19       Impact factor: 14.307

2.  Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy.

Authors:  A A Ashkar; J P Di Santo; B A Croy
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

3.  The involvement of interleukin (IL)-15 in regulating the differentiation of granulated metrial gland cells in mouse pregnant uterus.

Authors:  W Ye; L M Zheng; J D Young; C C Liu
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

Review 4.  Tissue-Resident NK Cells: Development, Maturation, and Clinical Relevance.

Authors:  Elaheh Hashemi; Subramaniam Malarkannan
Journal:  Cancers (Basel)       Date:  2020-06-12       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.